Man Group’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-11,600
Closed -$2.13M 2197
2021
Q2
$2.13M Sell
11,600
-41,186
-78% -$7.07M 0.01% 1206
2021
Q1
$8.07M Sell
52,786
-812,208
-94% -$126M 0.04% 501
2020
Q4
$135M Sell
864,994
-500,900
-37% -$64.4M 0.59% 20
2020
Q3
$156M Buy
1,365,894
+826,091
+153% +$89.1M 0.62% 22
2020
Q2
$60.6M Buy
539,803
+53,815
+11% +$5.71M 0.31% 65
2020
Q1
$43.6M Sell
485,988
-351,065
-42% -$34.5M 0.28% 76
2019
Q4
$90.5M Buy
837,053
+323,949
+63% +$34.6M 0.3% 63
2019
Q3
$50.3M Buy
513,104
+398,394
+347% +$44.9M 0.19% 114
2019
Q2
$15M Buy
114,710
+91,528
+395% +$11.8M 0.05% 447
2019
Q1
$3.13M Sell
23,182
-83,180
-78% -$10.3M 0.01% 1147
2018
Q4
$10.4M Sell
106,362
-11,539
-10% -$1.36M 0.05% 443
2018
Q3
$16.4M Buy
117,901
+41,610
+55% +$5.22M 0.06% 395
2018
Q2
$9.47M Sell
76,291
-47,784
-39% -$5.58M 0.04% 611
2018
Q1
$13.8M Buy
+124,075
New +$14.8M 0.06% 346

Other funds holding ALXN